Clinical trial

Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease

NCT00442780

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention BIIB014 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-08-01

PhasePHASE2

Conditions

Parkinson's Diseaseverified · MONDO: Parkinson disease

Interventions

BIIB014DRUG

PlaceboDRUG

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

BelgradeSerbia2 WarsawPoland1 KrakowPoland1 PoznanPoland1 Tel AvivIsrael1 Petah TikvaIsrael1 Ramat GanIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00442780 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.